Conmed Corp. (NASDAQ:CNMD) on 11/08/2018 declared a dividend of $ 0.2000 per share payable on January 07, 2019 to shareholders of record as of December 14, 2018.

Conmed Corp. (NASDAQ:CNMD) has paid dividends since 2012, has a current dividend yield of 1.17% and has increased its dividends for 0 successive years.

Conmed Corp.'s market cap is $ 1,925,148,760 and has a PE ratio of 26.42. The stock price closed yesterday at $ 68.44 and has a 52 week low/high of $ 49.22 and $ 83.49.

CONMED is a medical technology company that provides surgical devices and equipment for minimally invasive procedures in orthopedics, general surgery, gynecology, neurosurgery and gastroenterology. Co.'s orthopedic surgery product offering includes sports medicine, powered surgical instruments, and sports biologics and tissue. Under the Sports Medicine Joint Development and Distribution Agreement, Co. promotes allograft tissues, which includes the reconstruction and replacement of tendon, ligament, cartilage or menisci, along with the correction of deformities. Co.'s general surgery product line provides products in the areas of advanced surgical, endoscopic technologies and critical care.

For more information on Conmed Corp. click here.